Ad hoc release: PAION announces that NMPA accepts submission of New Drug Application for remimazolam by Chinese licensee Yichang Humanwell

PAION announces that NMPA accepts submission of New Drug Application for remimazolam by Chinese licensee Yichang Humanwell